[
  {
    "prevalence_id": "14562",
    "orpha_code": "536",
    "disease_name": "Systemic lupus erythematosus",
    "source": "6929995[PMID]_28968809[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "537",
    "orpha_code": "3099",
    "disease_name": "Rheumatic fever",
    "source": "23254495[PMID]_21386976[PMID]_ [EXPERT]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "701",
    "orpha_code": "636",
    "disease_name": "Neurofibromatosis type 1",
    "source": "2518509[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16897",
    "orpha_code": "716",
    "disease_name": "Phenylketonuria",
    "source": "32668217[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1660",
    "orpha_code": "418",
    "disease_name": "Congenital adrenal hyperplasia",
    "source": "3259306[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1972",
    "orpha_code": "375",
    "disease_name": "Anti-glomerular basement membrane disease",
    "source": "22032242[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2053",
    "orpha_code": "442",
    "disease_name": "Congenital hypothyroidism",
    "source": "22723332[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2054",
    "orpha_code": "442",
    "disease_name": "Congenital hypothyroidism",
    "source": "22723332[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Class only",
    "geographic_area": "New Zealand",
    "validation_status": "Not yet validated",
    "reliability_score": 6.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "1993",
    "orpha_code": "727",
    "disease_name": "Microscopic polyangiitis",
    "source": "16368729[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2014",
    "orpha_code": "900",
    "disease_name": "Granulomatosis with polyangiitis",
    "source": "16368729[PMID]_25805746[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "16279",
    "orpha_code": "549",
    "disease_name": "Legionnaires disease",
    "source": "31294928[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "2380",
    "orpha_code": "2137",
    "disease_name": "Autoimmune hepatitis",
    "source": "20880179[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "3580",
    "orpha_code": "2322",
    "disease_name": "Kabuki syndrome",
    "source": "15108197[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17337",
    "orpha_code": "271861",
    "disease_name": "Hereditary ATTR amyloidosis",
    "source": "29211930[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8655",
    "orpha_code": "206647",
    "disease_name": "Myotonic dystrophy",
    "source": "16964297[PMID]_25532075[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4498",
    "orpha_code": "538",
    "disease_name": "Lymphangioleiomyomatosis",
    "source": "21764810[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 1 000 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 5.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "4847",
    "orpha_code": "3280",
    "disease_name": "Syringomyelia",
    "source": "16549414[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "17054",
    "orpha_code": "79140",
    "disease_name": "Cutaneous neuroendocrine carcinoma",
    "source": "33932460[PMID]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 9.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "5468",
    "orpha_code": "33475",
    "disease_name": "Meningococcal meningitis",
    "source": "Institute of Environmental Science and Research 2011[INST]",
    "prevalence_type": "Annual incidence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 7.5,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7070",
    "orpha_code": "90794",
    "disease_name": "Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "source": "7815200[PMID]",
    "prevalence_type": "Prevalence at birth",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 9.8,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "14111",
    "orpha_code": "98879",
    "disease_name": "Hemophilia B",
    "source": "21649801[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "7650",
    "orpha_code": "98878",
    "disease_name": "Hemophilia A",
    "source": "19845775[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-5 / 10 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 300.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  },
  {
    "prevalence_id": "8038",
    "orpha_code": "101997",
    "disease_name": "Primary immunodeficiency",
    "source": "17588141[PMID]",
    "prevalence_type": "Point prevalence",
    "prevalence_class": "1-9 / 100 000",
    "qualification": "Value and class",
    "geographic_area": "New Zealand",
    "validation_status": "Validated",
    "reliability_score": 10.0,
    "is_fiable": true,
    "per_million_estimate": 50.0,
    "confidence_level": "high",
    "estimate_source": "class_midpoint"
  }
]